Long-Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 or AMB-321

Grants and Contracts Details

StatusFinished
Effective start/end date9/1/054/30/06

Funding

  • Myogen Inc: $3,150.00